<DOC>
	<DOCNO>NCT01258530</DOCNO>
	<brief_summary>This study healthy adult volunteer assess bioequivalence over-encapsulated oseltamivir capsule commercially available oseltamivir capsule . Both formulation administer fast state .</brief_summary>
	<brief_title>A Study Evaluate Bioequivalence Over-encapsulated Oseltamivir Capsules Marketed Oseltamivir Capsules Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>AST , ALT , alkaline phosphatase bilirubin great equal 1.5xULN ( isolated bilirubin &gt; 1.5xULN acceptable bilirubin fractionate direct bilirubin &lt; 35 % ) . Healthy determine responsible experienced physician , base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . Male female 18 65 year age inclusive , time signing informed consent . A female subject eligible participate : Childbearing potential agrees use one contraception method list protocol appropriate period time ( determined product label investigator ) prior start dose sufficiently minimize risk pregnancy point . Female subject must agree use contraception followup visit . Body weight great equal 50 kg BMI within range 18.5 31.0 kg/m2 ( inclusive ) . Capable give write informed consent , include compliance requirement restriction list consent form . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result within 3 month screen Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) . A positive prestudy drug/alcohol screen . A minimum list drug screen include amphetamine , barbiturate , cocaine , opiates , cannabinoids benzodiazepine . A positive test HIV antibody . History regular alcohol consumption within 6 month study define : average weekly intake &gt; 14 drink male &gt; 7 drink female . One drink equivalent 12 g alcohol : 12 ounce ( 360 ml ) beer , 5 ounce ( 150 ml ) wine 1.5 ounce ( 45 ml ) 80 proof distil spirit . The subject participate clinical trial receive investigational product within following time period prior first dose day current study : 30 day , 5 halflives twice duration biological effect investigational product ( whichever longer ) . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) prior first dose study medication , unless opinion Investigator GSK Medical Monitor medication interfere study procedure compromise subject safety . History sensitivity study medication , component thereof history drug allergy , opinion investigator GSK Medical Monitor , contraindicate participation . Where participation study would result donation blood blood product excess 500 mL within 56 day period . Pregnant female determine positive serum urine hCG test screen prior dosing . Lactating female . Unwillingness inability follow procedure outline protocol . Subject mentally legally incapacitate . History sensitivity heparin heparininduced thrombocytopenia . Urinary cotinine level indicative smoke history regular use tobacco nicotinecontaining product within 6 month prior screen . Consumption red wine , seville orange , grapefruit grapefruit juice 7 day prior first dose study medication . Subjects preexist condition interfere normal gastrointestinal anatomy motility , hepatic and/or renal function , could interfere absorption , metabolism , and/or excretion study drug . Subjects history cholecystectomy , peptic ulceration , inflammatory bowel disease pancreatitis exclude . The subject 's systolic blood pressure outside range 90140 mmHg , diastolic blood pressure outside range 4590 mmHg heart rate outside range 50100 bpm female subject 45100 bpm male subject . Exclusion criterion screen ECG ( single repeat allow eligibility determination ) : Heart rate Males &lt; 45 &gt; 100 bpm Females &lt; 50 &gt; 100 bpm ; PR Interval &lt; 120 &gt; 220 msec ; QRS duration &lt; 70 &gt; 120 msec ; QTc interval ( Bazett ) &gt; 450 msec . Evidence previous myocardial infarction ( Does include ST segment change associate repolarization ) . Any conduction abnormality ( include specific leave right complete bundle branch block , AV block [ 2nd degree high ] , Wolf Parkinson White [ WPW ] syndrome , nonsustained sustain ventricular tachycardia ( great equal 3 consecutive ventricular ectopic beat ) .sinus pause &gt; 3 second , significant arrhythmia , opinion principal investigator GSK medical monitor , interfere safety individual subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>influenza , bioequivalence , oseltamivir , Tamiflu , over-encapsulation</keyword>
</DOC>